180 Life Sciences Corp.
ATNF
$2.00
$0.010.50%
Corporate Info
650 507 0669
Building 4
Suite 200
3000 El Camino Real
Palo Alto, CA 94306
Suite 200
3000 El Camino Real
Palo Alto, CA 94306
United States
--
Details
Health Care
Pharmaceuticals, Biotechnology and Life Sciences
4
Business Decription
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.